|
ELK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.85826917689747E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56794626965984E-12 |
| Normal-vs-Stage2 |
5.626700E-04 |
| Normal-vs-Stage3 |
4.65780000125093E-08 |
| Normal-vs-Stage4 |
1.32730049173801E-10 |
| Stage1-vs-Stage2 |
5.082800E-01 |
| Stage1-vs-Stage3 |
4.462600E-01 |
| Stage1-vs-Stage4 |
2.149600E-01 |
| Stage2-vs-Stage3 |
9.075800E-01 |
| Stage2-vs-Stage4 |
1.871780E-01 |
| Stage3-vs-Stage4 |
1.070400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.27404769961959E-12 |
| Normal-vs-AfricanAmerican |
5.8464999999952E-05 |
| Normal-vs-Asian |
3.88109999693853E-08 |
| Caucasian-vs-AfricanAmerican |
4.389600E-01 |
| Caucasian-vs-Asian |
3.294400E-01 |
| AfricanAmerican-vs-Asian |
9.691000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.78059999867264E-08 |
| Normal-vs-Female |
1.98518979033224E-12 |
| Male-vs-Female |
1.200750E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.18935980456081E-12 |
| Normal-vs-Age(41-60Yrs) |
1.92159954615079E-10 |
| Normal-vs-Age(61-80Yrs) |
3.06490000001602E-06 |
| Normal-vs-Age(81-100Yrs) |
5.863600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.198200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.173900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.923600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.516440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.031040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.823600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.293400E-01 |
| Classical-VS-Follicular |
1.13450360217371E-11 |
| Classical-VS-Other |
3.244200E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
1.200400E-04 |
| Tall-VS-Other |
6.554400E-01 |
| Tall-VS-Normal |
6.38589999768513E-08 |
| Follicular-VS-Other |
2.294400E-01 |
| Follicular-VS-Normal |
1.515610E-01 |
| Other-VS-Normal |
1.311220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97149999997737E-07 |
| Normal-vs-N1 |
1.98459999989353E-07 |
| N0-vs-N1 |
7.166500E-02 |
|
|
